SILENCE THER. (SLN)
08/01/2018 - 07:00 RNS
RNS Number: 1629B Silence Therapeutics PLC 08 January 2018 Post year end business update 8 January 2018 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces a post year end update. Arrowhead dis...
28/12/2017 - 07:26 StockMarketWire
Silence Therapeutics has sold a further part of its holding in Arrowhead Pharmaceuticals. Since an announcement on 11 D...
28/12/2017 - 07:00 RNS
Statement regarding the disposal of a company or assets
15/12/2017 - 16:40 RNS
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment